AbbVie (NY: ABBV )

108.41 USD +0.67 (+0.62%)

Official Closing Price Updated: 7:45 PM EST, Mar 1, 2021 Add to My Watchlist

Price and Volume

Volume	4,710,305
Open	108.53
Bid (Size)	108.21 (1)
Ask (Size)	108.69 (2)
Prev. Close	107.74
Today's Range	108.07 - 109.21
52wk Range	62.55 - 113.41
Shares Outstanding	1,586,879,451
Dividend Yield	3.31%

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Allergan, an AbbVie Company, Submits New Drug Application for Investigational AGN-190584 for the Treatment of Presbyopia

February 25, 2021

- If approved, this is expected to be the first eye drop to treat presbyopia

Are These Top Health Care Stocks Worth Watching Ahead Of March?

February 25, 2021

Performance

YTD	+2.85%	+2.85%
1 Month	+5.79%	+5.79%
3 Month	+3.66%	+3.66%
6 Month	+13.20%	+13.20%
1 Year	+22.23%	+22.23%

More News

HUMIRA® (adalimumab) Receives FDA Approval to Treat Pediatric Patients Living with Moderately to Severely Active Ulcerative Colitis

February 24, 2021

New REFRESH® DIGITAL Lubricant Eye Drops Tackle Eye Dryness Due to Everyday Screen Use

February 23, 2021

Second Phase 3 Induction Study Confirms Upadacitinib (RINVOQ™) Improved Clinical, Endoscopic and Histologic Outcomes in Ulcerative Colitis Patients

February 22, 2021

MORF Stock: Why Little-Known Morphic Holdings Is Up 100% Today

Today 12:30 EST

7 Safe Stocks You Can Hold Onto Forever

Today 11:52 EST

Warren Buffett Says Berkshire's Apple Investment Shows The 'Power Of Repurchases'

Today 2:28 EST

AbbVie's Allergan Files US Application AGN-190584 For Presbyopia

February 25, 2021

Buffett Just Bought $8 Billion Of This 5G Stock

February 26, 2021

AbbVie's Humira Gets FDA Approval For Pediatric Ulcerative Colitis

February 25, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.